Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CYCLOPENTOLATE - Health Canada Drug Approval Details

Approvals/Health Canada/CYCLOPENTOLATE

Authorized

STANDARD

CYCLOPENTOLATE

pharma stulln inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: ad70ff152639a14a
Company: pharma stulln inc.
Type: Standard

Approval Details

Approval Id: ad70ff152639a14a
Drug Approval Canada Name: CYCLOPENTOLATE
Product Name: CYCLOPENTOLATE
Status: Cancelled Post Market
Status Date: 2020-01-15
Original Market Date: 1994-12-31
Din: 02023644
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:24.00
Atc Original: S01FA04 CYCLOPENTOLATE
Atc Name: s 01 fa 04
Aig Number: 0108675001
Company Name: pharma stulln inc.
Company Address: 6500 Trans Canada Highway, Suite 400, Pointe-Claire, Quebec, Canada, H9R 0A5

Active Ingredients

CYCLOPENTOLATE HYDROCHLORIDE

1 %

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ad70ff152639a14a

Type

Standard

Back to Health Canada Approvals